Nouscom AG
Research - , Basel City, Switzerland
Nouscom AG Employees
Biljana Petrovic
Development of personalized antitumor vaccine. Engineering
Nouscom AG Details
Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos (acquired by GSK), and are veterans in the field of genetic vaccines. Nouscom, which was founded in 2015 and is headquartered in Basel, Switzerland with operations in Rome, Italy, is backed by international life sciences investors: 5AM, Abingworth, LSP (Life Sciences Partners) and Versant Ventures. For more information on Nouscom, please visit the company's website at www.nouscom.com
Nouscom AG Technologies
Domain Name Services
Cloudflare DNS
CMS
WordPress.org
Tag Management
Google Tag Manager
Hosting
Google Cloud Hosting
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework